Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
Date:3/26/2009

d notes 118,534 - Accounts payable 5,736 2,856 Accrued liabilities 19,024 29,047 Purchased product rights liability 14,000 - Deferred revenue 12,322 1,494 ------ ----- Total current liabilities 173,491 36,856 Non-current portion of deferred revenue 11,330 12,468 Liability under government settlement 13,063 14,881 Senior secured notes - 75,116 Common stock subject to repurchase 12,492 13,241 Stockholders' equity (deficit) (92,878) 54,992 ------- ------ Total liabilities and stockholders' equity (deficit) $117,498 $207,554 ======== ========


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 Nearly ... been filed in a consolidated litigation now underway ... , Documents recently updated in the Philadelphia ... in the state proceeding, all of which involve ... and other psychiatric conditions. Many of the cases ...
(Date:11/27/2014)... Randy Dotinga HealthDay Reporter , ... seem pre-wired to acquire a second language, new research suggests. ... will likely gain a brain boost, the small study finds. ... learning," said study co-author Ping Li, co-director of the Center ... it,s even more interesting, Li said, that "the brain networks ...
(Date:11/27/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Most babies ... a cold, the U.S. Food and Drug Administration says. ... be given to children younger than 2 because they ... agency warned. American adults average about three colds ... children get a cold, parents might want to give ...
(Date:11/27/2014)... Dennis Thompson HealthDay Reporter ... experimental Ebola vaccine appears to be safe and produces an ... virus, according to early clinical trial results reported by the ... phase I clinical trial for the vaccine paves the way ... Liberia and Sierra Leone as early as January, said Dr. ...
(Date:11/27/2014)... (HealthDay News) -- Thanksgiving meals can pose a challenge ... an expert says. Many traditional Thanksgiving dishes -- ... -- are gluten-free, but "when it comes to pies, ... considered," Dr. Anca Safta, director of the Gluten and ... Center in North Carolina, said in a center news ...
Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Expert Shares Gluten-Free Thanksgiving Tips 2
... in 2007, Blue Cross Blue Shield of Georgia (BCBSGa) announced ... clinical psychologists by approximately 19%. This new rate is ... home handyman per hour. However, unlike your mechanic, BCBSGa ... were paid 10 years ago by BCBSGa. In 1998 ...
... there is nearly instant relief for those who suffer from ... and true Amish formula was recently secured by Caleb Treeze ... first time via the Internet.With an estimated 70% of adults ... time leg cramps, the problem is widespread. With this ...
... Dr. Michael J. Kussman, the Under Secretary for Health for ... to retire from federal service by May 9, ending a ... of brigadier general while in the U.S. Army, has been ... Dr. Kussman has directed a health care system with an ...
... Dr. Jeffrey Meyer, and Head of Neurochemical Imaging in ... Health (CAMH), is the first psychiatrist to be honoured with ... 60 year history. , For over 30 years, scientists ... and dopamine are low in the brain during episodes ...
... Emergency Responders, Treatment of Trauma Victims -ST. PETERSBURG, Fla., ... world,s first medical identification franchise providing consumers with a ... of trauma victims or those unable to communicate, is ... the Ft. Lauderdale market is now open for franchise ...
... Shamir Optical Industry Ltd. (Nasdaq: SHMR ) ... to the ophthalmic lens market, today announced that the Company ... the Company no longer complies with the audit committee composition ... a listed company to have an audit committee of at ...
Cached Medicine News:Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 2Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 3Health News:Night Time Cramps No More, Amazing Amish Formula from Caleb Treeze Organic Farm Provides Instant Relief 2Health News:Michael J. Kussman, VA Under Secretary for Health, to Retire 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Ft. Lauderdale For Franchise Sales 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Ft. Lauderdale For Franchise Sales 3Health News:Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Noncompliance with Nasdaq Audit Committee Composition Requirements 2
(Date:11/27/2014)... - New Solution That Makes ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" ... yen or $5,000 (without tax /including two pairs of JINS ... a dedicated solution of "JINS MEME" to academic researchers, and ... generated by electrooculography and six-axis sensors without API. (*Physiological data ...
(Date:11/26/2014)... 2014  Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... On Tuesday, December 2, the company will ... Healthcare Conference.  D. Keith Grossman , President and ... company beginning at 11:30 a.m., Eastern Standard Time (8:30 ...
(Date:11/26/2014)...   Royal Philips (NYSE: ... of its portfolio of diagnostic X-ray solutions ... , ProGrade and PrimaryDiagnost[ii]. With new releases of ... U.S., and availability of all these solutions in ... innovative solutions designed to meet the needs and ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
... -- Cylene Pharmaceuticals, Inc. has been selected to ... at the 52nd Annual Meeting of the American Society of ... FL, the company announced today.  Kenna Anderes, VP Cancer Biology ... kinase that is essential for the progression of multiple myeloma ...
... 2010 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... first time at the 52nd Annual Meeting of ... activity, safety and tolerability of perifosine in patients ... lymphoma (HL).  KRX-0401 (perifosine) is the Company,s novel, ...
Cached Medicine Technology:Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 2Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 3Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 2Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 3Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 4Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 5
The maternity apron is a very critical protection device for the patient and the fetus....
... our coat apron, weight is distributed ... of comfortable wear without fatigue. Made ... our front closing special procedure apron ... closures that make it a cinch ...
... X-ray Aprons are the result of a ... leaded x-ray aprons. Constructed with a wear ... back, the Lead Free aprons exhibit the ... apron. Each apron weighs approximately 50% less ...
... The Triage BNP Test is the ... test measuring B-type natriuretic peptide (BNP) ... ventricles in response to ventricular volume ... marker of ventricular systolic and diastolic ...
Medicine Products: